Filana Therapeutics, Inc. (FLNA)
0.808
-0.01
(-0.94%)
USD |
NASDAQ |
Oct 08, 09:35
Filana Therapeutics Enterprise Value : -43.28M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | -43.28M |
| October 06, 2026 | -40.42M |
| October 05, 2026 | -40.66M |
| October 02, 2026 | -37.71M |
| October 01, 2026 | -36.06M |
| September 30, 2026 | -39.88M |
| September 29, 2026 | -38.01M |
| September 28, 2026 | -41.46M |
| September 25, 2026 | -46.54M |
| September 24, 2026 | -45.35M |
| September 23, 2026 | -40.65M |
| September 22, 2026 | -32.92M |
| September 21, 2026 | -46.96M |
| September 18, 2026 | -47.61M |
| September 17, 2026 | -47.90M |
| September 16, 2026 | -49.63M |
| September 15, 2026 | -49.03M |
| September 14, 2026 | -47.96M |
| September 11, 2026 | -45.36M |
| September 10, 2026 | -43.60M |
| September 09, 2026 | -43.60M |
| September 08, 2026 | -44.17M |
| September 04, 2026 | -43.06M |
| September 03, 2026 | -42.67M |
| September 02, 2026 | -41.25M |
| Date | Value |
|---|---|
| September 01, 2026 | -41.27M |
| August 31, 2026 | -39.30M |
| August 28, 2026 | -37.80M |
| August 27, 2026 | -38.09M |
| August 26, 2026 | -38.03M |
| August 25, 2026 | -36.85M |
| August 24, 2026 | -37.75M |
| August 21, 2026 | -36.26M |
| August 20, 2026 | -37.15M |
| August 19, 2026 | -36.01M |
| August 18, 2026 | -40.80M |
| August 17, 2026 | -39.69M |
| August 14, 2026 | -38.56M |
| August 13, 2026 | -36.99M |
| August 12, 2026 | -37.60M |
| August 11, 2026 | -35.74M |
| August 10, 2026 | -34.50M |
| August 07, 2026 | -34.61M |
| August 06, 2026 | -36.35M |
| August 05, 2026 | -36.32M |
| August 04, 2026 | -34.55M |
| August 03, 2026 | -32.92M |
| July 31, 2026 | -33.89M |
| July 30, 2026 | -36.31M |
| July 29, 2026 | -40.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CorMedix, Inc. | 453.22M |
| Eloxx Pharmaceuticals, Inc. | -1.904M |
| BioStem Technologies, Inc. | 36.85M |
| Wave Life Sciences, Inc. | 237.19M |
| Axsome Therapeutics, Inc. | 8.951B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.603M |
| Total Expenses (Quarterly) | 8.603M |
| EPS Diluted (Quarterly) | -0.1781 |
| Earnings Yield | -108.3% |
| Normalized Earnings Yield | -108.32 |